12:00 AM
May 10, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Muse alprostadil: Marketed

Tulane University School of Medicine researchers presented data from 367 patients who took Muse after failing to respond to Pfizer Inc.’s

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >